Singapore markets close in 47 minutes
  • Straits Times Index

    2,976.35
    +27.31 (+0.93%)
     
  • Nikkei

    29,663.50
    +697.49 (+2.41%)
     
  • Hang Seng

    29,426.12
    +445.91 (+1.54%)
     
  • FTSE 100

    6,483.43
    0.00 (0.00%)
     
  • BTC-USD

    46,356.62
    +1,738.34 (+3.90%)
     
  • CMC Crypto 200

    926.46
    -6.68 (-0.72%)
     
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow

    30,932.37
    -469.63 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.95 (+0.56%)
     
  • Gold

    1,752.10
    +23.30 (+1.35%)
     
  • Crude Oil

    62.68
    +1.18 (+1.92%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,566.50
    -11.25 (-0.71%)
     
  • Jakarta Composite Index

    6,338.51
    +96.72 (+1.55%)
     
  • PSE Index

    6,872.97
    +78.11 (+1.15%)
     

Round 2: Measles vs. Cancer

Scientists at the Mayo Clinic are starting a second round of human clinical trials to test if an engineered strain of measles virus is an effective cancer treatment. The trial follows a successful first round of tests where a woman went into complete remission after a massive dose of the virus eradicated cancer in her body. Ben Gruber reports.